间充质干细胞
微载波
细胞生物学
运行x2
明胶
化学
活力测定
干细胞
转染
生物医学工程
骨愈合
细胞分化
再生医学
组织工程
细胞
微流控
材料科学
体外
转基因生物
细胞包封
碱性磷酸酶
成骨细胞
再生(生物学)
细胞培养
骨细胞
骨组织
骨形态发生蛋白2
分子生物学
细胞疗法
基因工程
作者
Wanchuan Ding,Zhiqiang Luo,Junyi Che,Jingjing Gan,Yuanjin Zhao
标识
DOI:10.1002/adhm.202505260
摘要
ABSTRACT Mesenchymal stem cells (MSCs) hold significant potential for bone healing. Current efforts focus on enhancing stem cell viability and differentiation potential to improve therapeutic outcomes. Here, we transfected bone MSCs (BMSCs) with RUNX2 plasmid nanoparticles (BMSCs pRUNX2 ) and encapsulated them into gelatin methacryloyl (GelMA) hydrogel microcarriers (BRGMs) for bone regeneration. As the BRGMs were generated from microfluidics, they possess uniform sizes and good injectability to fit the complex shapes of clinical bone defects. In addition, they can maintain the high cell viability and further osteogenic induction capacity of loaded engineered BMSCs pRUNX2 . Moreover, enhanced osteogenic differentiation of them in vitro was also proved by the detection of osteogenic differentiation genes and proteins expression, staining of alkaline phosphatase, and alizarin red. Based on these features, we have demonstrated satisfactory bone regeneration in situ when the BRGMs were added into 5 mm full‐thickness rat calvarial defects for 8 weeks. Therefore, we believed that the proposed microfluidic encapsulation of genetically engineered BMSCs platform is a promising candidate for bone defect healing.
科研通智能强力驱动
Strongly Powered by AbleSci AI